tryptophan has been researched along with imiquimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, T; Arioka, Y; Ito, H; Saito, K; Seishima, M | 1 |
1 other study(ies) available for tryptophan and imiquimod
Article | Year |
---|---|
Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.
Topics: Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Imiquimod; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymph Nodes; Lymphocytes, Tumor-Infiltrating; Membrane Glycoproteins; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Th1 Cells; Thymoma; Thyroid Neoplasms; Time Factors; Toll-Like Receptor 7; Tryptophan; Tumor Burden | 2015 |